India in final stages of framing protocols for clinical tria
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
India is in the final stages of framing a protocol for conducting a clinical trial for convalescent plasma therapy, which uses antibodies from the blood of cured patients, to treat severely-ill COVID-19 patients, a senior ICMR official said.

Kerala is set to become the first state in the country to commence the therapy to treat that critically-ill on a trial basis. The ICMR is learned to have given its nod to the state government for the first of its kind project, initiated by the prestigious Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), a top official had said.

The ICMR official on Thursday said they would need approval from the Drug Controller General of India (DCGI) before embarking on any clinical trial using the therapy.

He said that it is not currently used or prescribed for patients in India. "We are in the final stages of making a protocol for convalescent plasma therapy and after that, we will need approval from the DCGI. As of now, it will be used only in clinical trials," he said, adding that the therapy was successful in limited clinical trials in some countries on patients who were in a severe condition or on ventilator support.

Image source: John Hopkins
A●●●●●●h d●●●y and 35 others like this16 shares
Ak P●●●●r
Ak P●●●●r General Medicine
Nice information
Apr 11, 2020Like2